InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: Thurly post# 106629

Monday, 01/07/2013 1:23:08 PM

Monday, January 07, 2013 1:23:08 PM

Post# of 346002
Thurly I just don't see the FDA the way you do. IMO their first concern is safety. Bavi passes that test with ease! Their second concern is efficacy. Again Bavi passes the test. As far as the FDA "mood"...they are stressing that they are anxious to accelerate approvals of safe drugs for deadly diseases. Second line NSCLC certainly qualifies!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News